Weighing the Efficacy and Toxicity of CAR T-Cell Therapy
Researchers sought to determine the balance between the efficacy and toxicity when administering CAR T-cell therapy.
Caleb Rans, PharmD
Contributing Writer
Caleb Rans is a clinical pharmacist and medical communications specialist with professional expertise in medical writing, editing, and contract clinical research. He holds a PharmD from the University of Alberta and presently resides in Vancouver, Canada. He currently works as an independent consultant for several news, CME, and pharmaceutical companies.
